Join us for this exciting awards ceremony, where you'll first meet the three winners selected from 322 candidates across 27 countries who received accolades for the best clinical cases. Witness the presentation of the award-winning case titled 'Percutaneous Intervention of Stuck Prosthetic Mitral Valve'. Following that,...

Prepare to be captivated by a collection of intriguing STEMI cases, curated from the AICT-AsiaPCR 2024 submissions. From a left main PCI in a patient with dextrocardia to a challenging case of primary PCI in an aneurysmal coronary artery, this session promises to push the boundaries...

A 72-year-old lady with dyslipidemia, hypertension and aspirin intolerance presented an NSTEMI. The coronary angiography showed a distal CX occlusion and a long calcified significant stenosis on proximal LAD with LAD/D3 bifurcation lesion, and a reduced LV function (47%).
Watch the operators as they perform an important...

Intracoronary imaging plays a crucial role in guiding treatment strategies for complex lesions. This session delves into the use of various imaging modalities, such as IVUS and OCT, to optimize PCI outcomes. Explore real-world case examples, including a sudden coronary arrest caused by focal stenosis with...

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.